Roche Holding AG
๐จ๐ญSwitzerland
- Country
- ๐จ๐ญSwitzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
A Study of Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR Mutations
Phase 4
Completed
- Conditions
- Non-Squamous Non-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2012-06-01
- Last Posted Date
- 2016-02-01
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 62
- Registration Number
- NCT01609543
A Study of Rituximab (MabThera) in Combination With Chemotherapy in Participants With CD20-Positive B-Cell Chronic Lymphocytic Leukemia
- First Posted Date
- 2012-05-31
- Last Posted Date
- 2018-06-26
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 67
- Registration Number
- NCT01609023
- Locations
- ๐ฌ๐ท
Metropolitan Hospital; Hematology Dept, Athens, Greece
๐ฌ๐ทUniversity Hospital of Larissa; Hematology Dept., Larissa, Greece
๐ฌ๐ทLaiko General Hospital of Athens; A Propedeutical Clinic of Internal Medicine, Athens, Greece
An Observational Study of Peginterferon Alfa-2a in Combination With Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis
- First Posted Date
- 2012-05-31
- Last Posted Date
- 2017-04-12
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 1496
- Registration Number
- NCT01609049
- Locations
- ๐ท๐บ
Kirov Region Aids-Center; Infectious, Kirov, Russian Federation
๐ท๐บInfections Deseases Hospital #1, Novosibirsk, Russian Federation
๐ท๐บKrasnoyarsk Region Aids Center; Hepatology, Krasnoyarsk, Russian Federation
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer in Italy (BEWARE)
Completed
- Conditions
- Colorectal Cancer
- First Posted Date
- 2012-05-31
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 437
- Registration Number
- NCT01609075
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma
Terminated
- Conditions
- Lymphoma, Follicular
- First Posted Date
- 2012-05-31
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 3
- Registration Number
- NCT01609036
A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) Lymphoma
- First Posted Date
- 2012-05-31
- Last Posted Date
- 2014-09-08
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 313
- Registration Number
- NCT01609010
A Study of RO5045337 in Combination With Doxorubicin in Patients With Soft Tissue Sarcoma
- First Posted Date
- 2012-05-25
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 23
- Registration Number
- NCT01605526
An Observational Study of Dual and Triple Therapies Based on Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C
Completed
- Conditions
- Hepatitis C, Chronic
- First Posted Date
- 2012-05-23
- Last Posted Date
- 2019-03-14
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 991
- Registration Number
- NCT01604291
- Locations
- ๐ฎ๐ฑ
Tel-Aviv Sourasky Medical Center; Liver Unit, Tel Aviv, Israel
๐ฎ๐ฑHaemek Hospital; Gastroenterology, Afula, Israel
๐ฎ๐ฑBarzilai MC; Gastroenterology, Ashkelon, Israel
A Study of Drug-Drug Interaction Between Danoprevir Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or Atazanavir
Phase 1
Completed
- Conditions
- Healthy Volunteer
- Interventions
- First Posted Date
- 2012-05-07
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 40
- Registration Number
- NCT01592305
A Study of The Excretion Balance, Pharmacokinetics and Metabolism of A Single Oral Dose of [14C]-Labeled RO4917523 in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteer
- Interventions
- Drug: RO4917523
- First Posted Date
- 2012-05-07
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 6
- Registration Number
- NCT01592890
ยฉ Copyright 2025. All Rights Reserved by MedPath